Concepts (84)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 9 | 2022 | 302 | 1.890 |
Why?
|
| Magnetic Resonance Imaging | 11 | 2022 | 1310 | 1.150 |
Why?
|
| Tomography, Optical Coherence | 3 | 2023 | 47 | 1.040 |
Why?
|
| Brain | 7 | 2022 | 949 | 0.950 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2023 | 225 | 0.710 |
Why?
|
| Retinal Diseases | 1 | 2021 | 26 | 0.690 |
Why?
|
| Cerebellar Cortex | 1 | 2020 | 4 | 0.660 |
Why?
|
| Down Syndrome | 1 | 2020 | 13 | 0.650 |
Why?
|
| Retina | 4 | 2023 | 84 | 0.620 |
Why?
|
| Dementia | 1 | 2021 | 247 | 0.550 |
Why?
|
| Neurons | 1 | 2020 | 417 | 0.510 |
Why?
|
| Disease Progression | 5 | 2022 | 594 | 0.370 |
Why?
|
| Silicone Oils | 2 | 2016 | 10 | 0.350 |
Why?
|
| tau Proteins | 3 | 2021 | 39 | 0.310 |
Why?
|
| Sex Characteristics | 2 | 2021 | 174 | 0.290 |
Why?
|
| Lens, Crystalline | 1 | 2016 | 2 | 0.250 |
Why?
|
| Triamcinolone Acetonide | 1 | 2016 | 4 | 0.250 |
Why?
|
| Tissue Distribution | 1 | 2016 | 59 | 0.250 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 1582 | 0.230 |
Why?
|
| Longitudinal Studies | 4 | 2020 | 780 | 0.210 |
Why?
|
| Aging | 2 | 2021 | 955 | 0.200 |
Why?
|
| Animals | 7 | 2020 | 7599 | 0.200 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 1015 | 0.200 |
Why?
|
| Mice, Transgenic | 4 | 2019 | 259 | 0.190 |
Why?
|
| Cerebral Cortex | 2 | 2021 | 126 | 0.190 |
Why?
|
| Humans | 11 | 2022 | 32969 | 0.180 |
Why?
|
| Lasers | 1 | 2021 | 24 | 0.180 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2021 | 51 | 0.160 |
Why?
|
| Gadolinium | 1 | 2020 | 20 | 0.160 |
Why?
|
| Staining and Labeling | 1 | 2020 | 58 | 0.160 |
Why?
|
| Radiopharmaceuticals | 1 | 2021 | 93 | 0.160 |
Why?
|
| Image Enhancement | 1 | 2020 | 70 | 0.160 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 770 | 0.160 |
Why?
|
| Contrast Media | 1 | 2020 | 139 | 0.150 |
Why?
|
| Positron-Emission Tomography | 1 | 2021 | 168 | 0.150 |
Why?
|
| Frontotemporal Dementia | 1 | 2019 | 5 | 0.150 |
Why?
|
| Optic Nerve | 1 | 2019 | 16 | 0.150 |
Why?
|
| Retinal Degeneration | 1 | 2019 | 22 | 0.140 |
Why?
|
| Data Interpretation, Statistical | 1 | 2018 | 115 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 790 | 0.140 |
Why?
|
| Male | 6 | 2021 | 19754 | 0.130 |
Why?
|
| Databases, Factual | 1 | 2018 | 369 | 0.130 |
Why?
|
| Psychomotor Disorders | 1 | 2016 | 4 | 0.130 |
Why?
|
| Huntington Disease | 1 | 2016 | 15 | 0.120 |
Why?
|
| Tauopathies | 1 | 2015 | 1 | 0.120 |
Why?
|
| Neurofibrillary Tangles | 1 | 2015 | 4 | 0.120 |
Why?
|
| Atlases as Topic | 1 | 2014 | 10 | 0.100 |
Why?
|
| Aged | 3 | 2021 | 10637 | 0.090 |
Why?
|
| Mice | 2 | 2016 | 2529 | 0.090 |
Why?
|
| Survival Analysis | 2 | 2022 | 486 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 4065 | 0.080 |
Why?
|
| Female | 4 | 2021 | 20375 | 0.070 |
Why?
|
| Atrophy | 2 | 2016 | 46 | 0.060 |
Why?
|
| Swine | 1 | 2016 | 216 | 0.060 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 105 | 0.060 |
Why?
|
| Angiography | 1 | 2021 | 80 | 0.040 |
Why?
|
| Genomics | 1 | 2022 | 88 | 0.040 |
Why?
|
| Organ Size | 1 | 2021 | 220 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2021 | 224 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2021 | 134 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 765 | 0.040 |
Why?
|
| Research Design | 1 | 2021 | 334 | 0.040 |
Why?
|
| Retinal Ganglion Cells | 1 | 2019 | 30 | 0.040 |
Why?
|
| Algorithms | 1 | 2021 | 517 | 0.040 |
Why?
|
| Age Factors | 1 | 2021 | 1202 | 0.030 |
Why?
|
| Species Specificity | 1 | 2016 | 89 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 76 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 1547 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2016 | 99 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2016 | 117 | 0.030 |
Why?
|
| Doxycycline | 1 | 2015 | 26 | 0.030 |
Why?
|
| Transgenes | 1 | 2015 | 50 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2016 | 179 | 0.030 |
Why?
|
| Gene Expression | 1 | 2016 | 336 | 0.030 |
Why?
|
| Time Factors | 1 | 2020 | 2195 | 0.030 |
Why?
|
| Body Weight | 1 | 2016 | 302 | 0.030 |
Why?
|
| Hippocampus | 1 | 2015 | 171 | 0.030 |
Why?
|
| Specific Gravity | 1 | 2013 | 2 | 0.030 |
Why?
|
| Spectrophotometry | 1 | 2013 | 22 | 0.030 |
Why?
|
| Silicon Dioxide | 1 | 2013 | 10 | 0.030 |
Why?
|
| Rabbits | 1 | 2013 | 193 | 0.020 |
Why?
|
| Materials Testing | 1 | 2013 | 92 | 0.020 |
Why?
|
| Models, Animal | 1 | 2013 | 173 | 0.020 |
Why?
|
| Middle Aged | 1 | 2019 | 12203 | 0.010 |
Why?
|